CC
MRTX

Centiva Capital’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Centiva Capital’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-200
Closed -$14K – 1770
2022
Q3 		$14K Sell
200
-825
-80% -$61K ﹤0.01% 1391
2022
Q2 		$69K Buy
+1,025
New +$65.2K ﹤0.01% 1462
2021
Q4 		– Sell
-1,071
Closed -$189K – 1674
2021
Q3 		$189K Sell
1,071
-3,645
-77% -$586K 0.02% 946
2021
Q2 		$762K Sell
4,716
-641
-12% -$103K 0.06% 676
2021
Q1 		$918K Buy
5,357
+1,051
+24% +$208K 0.13% 389
2020
Q4 		$946K Buy
4,306
+2,649
+160% +$573K 0.12% 283
2020
Q3 		$275K Sell
1,657
-5,402
-77% -$739K 0.04% 499
2020
Q2 		$806K Buy
+7,059
New +$685K 0.18% 211

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return